Recent Company News

• 10:38 PM ET Mar 27, 2025
  

  Kaken Pharmaceutical notes partner Almirall S.A. receives marketing authorization for Efinaconazole in Italy (¥4520.0000, -68)

• 05:24 AM ET Mar 20, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (75 total)

• 08:19 AM ET Mar 12, 2025
  

  StreetAccount Summary - European unusual volume traders

• 06:33 AM ET Mar 07, 2025
  

  Almirall presents early-stage pipeline progress and real-world evidence on demonstrating AK treatment success and patient satisfaction with tirbanibulin (€9.85, -0.28)

• 02:07 AM ET Mar 06, 2025
  

  Almirall CFO Mike McClellan to leave in September (€9.95, 0.00)

• 04:01 AM ET Feb 28, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (106 total)

• 04:06 AM ET Feb 24, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:34 AM ET Feb 25, 2025
  

  Almirall upgraded to outperform from neutral at Oddo (€9.45, 0.00)

• 02:57 AM ET Feb 24, 2025
  

  StreetAccount Summary - European pre-market trading update